Log in
Enquire now
‌

US Patent 8206919 Gene expression markers for breast cancer prognosis

Patent 8206919 was granted and assigned to Genomic Health on June, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Genomic Health
Genomic Health
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8206919
Date of Patent
June 26, 2012
Patent Application Number
13221549
Date Filed
August 30, 2011
Patent Citations Received
‌
US Patent 12125561 Determination of JAK-STAT3 pathway activity using unique combination of target genes
0
‌
US Patent 11776661 Determination of MAPK-AP-1 pathway activity using unique combination of target genes
Patent Primary Examiner
‌
Christopher M Babic
Patent abstract

The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8206919 Gene expression markers for breast cancer prognosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.